TNFSF15 rs1883375: Genetics, Gut Health, and IBD Risk
The rs1883375 variant is a common single nucleotide polymorphism located in the regulatory region of the TNFSF15 gene on chromosome 9. Research has linked this variant to altered susceptibility to inflammatory bowel diseases, specifically Crohn's disease and ulcerative colitis. However, because it confers only a modest statistical change in risk, carrying this variant is not a medical diagnosis.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| CC | Carriers of the CC genotype possess two copies of the C allele. In published inflammatory bowel disease cohorts, this genotype is generally associated with typical baseline population risk or a lower relative risk compared to risk-associated alleles. | Informational |
| CT | Heterozygous individuals carry one copy of the C allele and one copy of the T allele. This intermediate genotype confers an average or slightly shifted susceptibility to Crohn's disease and ulcerative colitis, in line with polygenic risk models. | Informational |
| TT | Homozygous carriers of the T allele carry two copies of the variant frequently linked to altered TNFSF15 regulatory activity. In epidemiological studies, this genotype shows a modest statistical association with higher susceptibility to inflammatory bowel diseases. | Higher attention |
Genetic Architecture and Variant Location
The single nucleotide polymorphism rs1883375 is mapped to the TNFSF15 gene locus on human chromosome 9q32. Rather than altering the amino acid sequence of a protein, rs1883375 resides within a non-coding regulatory domain that includes the gene's promoter and intronic segments. In human genomics, variations in non-coding regulatory zones often influence how easily cellular machinery can bind to DNA to initiate transcription. Because rs1883375 is inherited alongside a broader haplotype block of adjacent genetic markers in high linkage disequilibrium, it serves as a representative tag for genetic variation across the TNFSF15 locus. Genomic databases like dbSNP and Ensembl track these subtle nucleotide substitutions to evaluate how regulatory polymorphisms alter tissue-specific expression without directly disrupting protein structure.
The Biological Role of TNFSF15
The TNFSF15 gene provides instructions for producing Tumor Necrosis Factor Superfamily Member 15, also widely referred to as TL1A or vascular endothelial growth inhibitor (VEGI). This signaling cytokine is expressed primarily by antigen-presenting immune cells, including monocytes, macrophages, and dendritic cells, as well as endothelial cells. TL1A interacts with its corresponding receptor, death receptor 3 (DR3), to regulate immune responses, stimulate lymphocyte activation, and guide mucosal barrier defenses within the gastrointestinal tract. Balanced expression of TL1A is vital for clearing pathogens and maintaining intestinal homeostasis; when signaling pathways are dysregulated, chronic mucosal inflammation can emerge. Functional investigations suggest that polymorphisms in this region alter baseline and stimulated TL1A expression, subtly modifying host vulnerability to autoimmune inflammation.
Evidence for Inflammatory Bowel Disease Susceptibility
Multiple genome-wide association studies (GWAS) and fine-mapping initiatives have documented associations between TNFSF15 variants and inflammatory bowel disease (IBD), spanning Crohn's disease and ulcerative colitis. First highlighted in East Asian populations and subsequently replicated across European cohorts, variants across TNFSF15 represent well-established polygenic markers. However, rs1883375 itself is considered to have limited to modest individual evidence strength when viewed in isolation, as it primarily operates as part of a collective haplotype rather than acting as a singular, deterministic driver. Odds ratios for individual alleles in this locus are typically small, modifying relative disease predisposition slightly above or below population baseline rather than ensuring disease onset.
Population Diversity and Allele Frequencies
The alleles of rs1883375 are common across diverse human ancestries, though notable frequency differences exist between continental groups. In both East Asian and European populations, the minor allele occurs frequently, with frequencies generally reported between 0.20 and 0.40 in large population resources such as the Genome Aggregation Database (gnomAD). In certain East Asian cohorts, TNFSF15 variants account for a more substantial fraction of the population-attributable genetic risk for Crohn's disease compared to European cohorts, where other inflammatory loci, such as NOD2, predominate. Such ancestry-specific differences underscore the fact that genetic risk architecture is shaped by evolutionary history and population backgrounds.
Interpreting Results and Clinical Realities
Understanding your rs1883375 genotype provides insight into your inherited baseline biology, but it cannot be used to diagnose Crohn's disease or ulcerative colitis. Inflammatory bowel disease is a complex, multifactorial disorder caused by interactions among hundreds of genetic variants, the gut microbiome, environmental triggers, smoking status, and immune regulation. Possessing an association-linked allele does not mean an individual will develop chronic gut inflammation, nor does a protective genotype guarantee immunity from disease. Genetic testing results from consumer platforms should never be used to initiate self-treatment or discontinue medications; any persistent gastrointestinal symptoms should be assessed directly by a qualified healthcare professional.
How common is this variant?
The minor allele for rs1883375 is common across human populations, with an estimated frequency of approximately 0.20 to 0.40 in European and East Asian cohorts in reference datasets like gnomAD.
Frequently asked questions
Does having the rs1883375 risk variant mean I will get Crohn's disease?
No. The rs1883375 variant provides only a minor contribution to overall genetic susceptibility and is not deterministic. Most individuals carrying risk-associated alleles at this locus never develop Crohn's disease or ulcerative colitis.
What is the function of the TNFSF15 gene in the body?
TNFSF15 codes for a cytokine called TL1A that helps regulate the immune system and gut mucosal lining. It facilitates communication between immune cells to balance defense against pathogens with mucosal tolerance.
Can diet or lifestyle offset my genetic risk at rs1883375?
While genetics cannot be changed, maintaining a balanced diet, avoiding smoking, and supporting gut microbiome diversity contribute significantly to overall gastrointestinal health. Lifestyle factors interact dynamically with genetic backgrounds to influence systemic inflammation.
Should I share my rs1883375 results with my doctor?
You can share genetic data with your healthcare provider if you have personal or family histories of gastrointestinal disorders. However, clinicians rely on clinical signs, endoscopies, and laboratory markers rather than single SNP tests to assess gut health.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1883375?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29